eazyScripts
eazyscripts.com
- Web
- API
5.8 Club score Visit eazyscripts.com
What the maker publishes
- API
- The e-prescribing API is REST-based and supports prescription submission. source
- API authentication
- API clients receive a subdomain, API key, and API secret code used for client identification and authentication. source
- Auditing
- The guide describes audit-trail access for reviewing prescriptions and data export for reports and audit trails. source
- Headquarters
- Akron, Ohio, United States source
- Integration model
- Some customers use their own user interfaces and connect to eazyScripts for certification and pharmacy prescription transmission. source
- Notable limitation
- In the 2023 real-world testing results, electronic renewal request responses measured 58.58%; the document attributed this partly to customer non-use of the feature. source
- Pharmacy network
- The guide describes prescription transmission through the SureScripts network and permits administrators to add pharmacies not found in that network. source
- Prescribing features
- Its listed prescribing capabilities include electronic prior authorization, controlled-substance prescribing, formulary support, and price transparency. source
- Product
- eazyScripts is a cloud-based electronic prescribing platform for ambulatory EHRs and standalone providers. source
- Refill and change workflows
- The dashboard includes prescription refill requests and pharmacy-requested changes to existing medications. source
- Security controls
- The user guide describes two-factor authentication using a one-time-password token when a provider signs. source
- Specialties
- The product supports multiple medical specialties, including general practice, behavioral health, urology, emergency medicine, pediatrics, dermatology, and pain management. source
- Updates
- The product's real-world testing document says updates are announced in release notes and tested in a non-production environment before production release. source
Checked against the maker's pages on 14 Nov 2026.